{
    "eid": "2-s2.0-85133866017",
    "title": "Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group",
    "cover-date": "2022-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pediatrics, Perinatology and Child Health",
            "@code": "2735",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "high risk",
        "neuroblastoma",
        "non-immunotherapy",
        "outcomes",
        "Thailand"
    ],
    "authors": [
        "Kunanya Suwannaying",
        "Chalinee Monsereenusorn",
        "Piya Rujkijyanont",
        "Piti Techavichit",
        "Kamon Phuakpet",
        "Pongpak Pongphitcha",
        "Su on Chainansamit",
        "Thirachit Chotsampancharoen",
        "Angkana Winaichatsak",
        "Chanchai Traivaree",
        "Lalita Sathitsamitphong",
        "Somjai Kanjanapongkul",
        "Patcharee Komvilaisak",
        "Kleebsabai Sanpakit",
        "Apichat Photia",
        "Panya Seksarn",
        "Surapon Wiangnon",
        "Suradej Hongeng"
    ],
    "citedby-count": 0,
    "ref-count": 35,
    "ref-list": [
        "Childhood cancer incidence and survival in Thailand: a comprehensive population-based registry analysis, 1990\u20132011",
        "Children's Oncology Group's 2013 blueprint for research: neuroblastoma",
        "Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma",
        "Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab beta",
        "Current Treatment of Neuroblastoma in Thailand: an experience of Thai Pediatric Oncology Group (ThaiPOG)",
        "Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study",
        "Treatment with topotecan plus cyclophosphamide in children with first relapse of neuroblastoma",
        "Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study",
        "The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report",
        "Effect of tandem autologous stem cell transplant vs single transplant on event-free survival in patients with high-risk neuroblastoma: a randomized clinical trial",
        "Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial",
        "Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group",
        "Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment",
        "Revisions to the International Neuroblastoma Response Criteria: a consensus statement from the National Cancer Institute clinical trials planning meeting",
        "Advances in risk classification and treatment strategies for neuroblastoma",
        "Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study",
        "Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma",
        "Predictors of differential response to induction therapy in high-risk neuroblastoma: a report from the Children's Oncology Group (COG)",
        "The role of surgery in high-risk neuroblastoma",
        "The optimal timing of surgical resection in high-risk neuroblastoma",
        "Roles of surgery in the treatment of patients with high-risk neuroblastoma in the Children's Oncology Group study: a systematic review and meta-analysis",
        "Local control in metastatic neuroblastoma in children over 1 year of age",
        "Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: patient characteristics, imaging, and outcome",
        "Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with (131) I-MIBG therapy for high-risk neuroblastoma",
        "The role of autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy. Results of two consecutive studies",
        "Neuroblastoma: experience from National University Health System, Singapore (1987\u20132008)",
        "Neuroblastoma: outcome over a 14 year period from a tertiary care referral centre in India",
        "Neuroblastoma in Iran: an experience of 32 years at a referral children's hospital",
        "Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a Children's Oncology Group study",
        "Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma",
        "Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age",
        "Upfront consolidation treatment with (131)I-mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high-risk neuroblastoma",
        "Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma",
        "Differentiating neuroblastoma: a systematic review of the retinoic acid, its derivatives, and synergistic interactions",
        "Revised neuroblastoma risk classification system: a report from the Children's Oncology Group"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60032250",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032250",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Ratchasima",
            "@id": "60013120",
            "affilname": "Maharaj Nakhon Ratchasima Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013120",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60012921",
            "affilname": "Khon Kaen Regional Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012921",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60010778",
            "affilname": "Queen Sirikit National Institute of Child Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010778",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Maha Sarakham",
            "@id": "60002875",
            "affilname": "Mahasarakham University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002875",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University"
    ]
}